ArticlePLoS medicine2007
Antibody-based HIV-1 vaccines: recent developments and future directions.
Article in PLoS medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed.
- Review
- Review
- Review
- HIV and SARS-CoV-2: Tracing a Path of Vaccine Research and Development.Current HIV/AIDS reports · 2022Review
- Article
- Article
- What Has 30 Years of HIV Vaccine Research Taught Us?Vaccines · 2013Article
- Organizing the HIV vaccine development effort.Current opinion in HIV and AIDS · 2013Review
- Preventive and therapeutic applications of neutralizing antibodies to Human Immunodeficiency Virus Type 1 (HIV-1).Therapeutic advances in vaccines · 2013Article
- Characterization and solution structure of the factor VIII C2 domain in a ternary complex with classical and non-classical inhibitor antibodies.The Journal of biological chemistry · 2013Article
- Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion.Journal of immunology (Baltimore, Md. : 1950) · 2013Article
- Autoreactivity and exceptional CDR plasticity (but not unusual polyspecificity) hinder elicitation of the anti-HIV antibody 4E10.PLoS pathogens · 2013Article
- Genetic imprint of vaccination on simian/human immunodeficiency virus type 1 transmitted viral genomes in rhesus macaques.PloS one · 2013Article
- Review
- A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays.Journal of virology · 2012Article
- Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model.Retrovirology · 2012Article
- Design and characterization of a peptide mimotope of the HIV-1 gp120 bridging sheet.International journal of molecular sciences · 2012Article
- Article
- International technology transfer of a GCLP-compliant HIV-1 neutralizing antibody assay for human clinical trials.PloS one · 2012Article
- Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine.Systems and synthetic biology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.